1. Home
  2. ACIU vs AVNW Comparison

ACIU vs AVNW Comparison

Compare ACIU & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACIU
  • AVNW
  • Stock Information
  • Founded
  • ACIU 2003
  • AVNW 2006
  • Country
  • ACIU Switzerland
  • AVNW United States
  • Employees
  • ACIU N/A
  • AVNW N/A
  • Industry
  • ACIU Biotechnology: Pharmaceutical Preparations
  • AVNW Radio And Television Broadcasting And Communications Equipment
  • Sector
  • ACIU Health Care
  • AVNW Technology
  • Exchange
  • ACIU Nasdaq
  • AVNW Nasdaq
  • Market Cap
  • ACIU 332.4M
  • AVNW 283.7M
  • IPO Year
  • ACIU 2016
  • AVNW 2007
  • Fundamental
  • Price
  • ACIU $2.71
  • AVNW $17.94
  • Analyst Decision
  • ACIU Strong Buy
  • AVNW Strong Buy
  • Analyst Count
  • ACIU 2
  • AVNW 5
  • Target Price
  • ACIU $12.00
  • AVNW $38.60
  • AVG Volume (30 Days)
  • ACIU 130.0K
  • AVNW 218.2K
  • Earning Date
  • ACIU 11-05-2024
  • AVNW 02-04-2025
  • Dividend Yield
  • ACIU N/A
  • AVNW N/A
  • EPS Growth
  • ACIU N/A
  • AVNW N/A
  • EPS
  • ACIU N/A
  • AVNW N/A
  • Revenue
  • ACIU $48,505,404.00
  • AVNW $409,603,000.00
  • Revenue This Year
  • ACIU $85.33
  • AVNW $9.06
  • Revenue Next Year
  • ACIU $80.69
  • AVNW $7.87
  • P/E Ratio
  • ACIU N/A
  • AVNW N/A
  • Revenue Growth
  • ACIU 4097200.00
  • AVNW 17.00
  • 52 Week Low
  • ACIU $2.25
  • AVNW $12.96
  • 52 Week High
  • ACIU $5.14
  • AVNW $38.85
  • Technical
  • Relative Strength Index (RSI)
  • ACIU 29.89
  • AVNW 57.16
  • Support Level
  • ACIU $2.62
  • AVNW $16.38
  • Resistance Level
  • ACIU $3.07
  • AVNW $17.34
  • Average True Range (ATR)
  • ACIU 0.15
  • AVNW 0.80
  • MACD
  • ACIU -0.04
  • AVNW 0.08
  • Stochastic Oscillator
  • ACIU 17.24
  • AVNW 69.96

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

About AVNW Aviat Networks Inc.

Aviat Networks Inc is a networking solutions provider. It designs, manufactures, and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.

Share on Social Networks: